Faculty and Staff
Janice Weinberg, ScD
Professor, Department of Biostatistics
Boston University School of Public Health
Director, MS in Clinical Research
Boston University School of Medicine
Dr. Janice Weinberg is the Director of the Master of Science in Clinical Research and a Professor of Biostatistics at the Boston University School of Public Health. She has extensive experience in the design, conduct and analysis of intervention trials and in serving as the biostatistician on clinical research projects. She has taught graduate level courses on clinical trials, correlated data analysis and statistical programming for many years. In addition, Dr. Weinberg reviewed a wide range of research as the statistical reviewer for the Institutional Review Board (IRB) for over a decade and has been the biostatistician member of many data safety monitoring boards for both industry and academia. She is currently a statistical consultant for the Clinical & Translational Science Institute (CTSI) and the lead statistical editor for the Journal of the American Heart Association (JAHA).
Stacey Hess Pino, MS, MS
Assistant Professor, Department of Medical Sciences & Education
Division of Graduate Medical Sciences
Boston University School of School of Medicine
Assistant Director, MS in Clinical Research
Director, Graduate Certificate Programs in Clinical Research
Boston University School of Medicine
Stacey is the Assistant Director of the MS in Clinical Research program at Boston University’s School of Medicine, and the Director of the Graduate Certificate Programs in Clinical Research at Boston University’s School of Medicine.
Stacey began her career as an exercise physiologist working in both the fitness and the clinical arenas. After a number of years, she obtained her graduate degree in research and worked in a variety of clinical research facilities in Massachusetts and in Florida.
In 2000 Stacey started working at the medical campus at Boston University performing research in the department of cardiology. She then moved to a position at BUMC’s Institutional Review Board, where she worked for 6+ years as a Senior IRB Analyst II. After her involvement at the IRB, Stacey moved over to the School of Medicine where she is now involved in the academic side of research.
Susan S. Fish, Pharm.D
Professor, Departments of Biostatistics and Epidemiology, Boston University, School of Public Health
Dr. Fish has a long history of research in the areas of clinical toxicology and emergency medicine. She has most recently focused on research ethics in general, and application of the federal regulations for waiver of informed consent in certain emergency research circumstances. Issues relating to the design of clinical research and ethical implications of study designs are Dr. Fish’s areas of expertise.
She is the former director of the IRB for the Boston University Medical Campus and Boston Medical Center. She is currently a member of faculty of Fordham University’s HIV and Drug Abuse Prevention Research Ethics Training Institute.
Amy Aulwes, JD, MPH
Amy has over 17 years of experience providing clinical and regulatory affairs consulting to industry sponsors and academic institutions. She specializes in regulatory strategy, product submissions and clinical study compliance. She has worked extensively with medical device, in vitro diagnostic and pharmaceutical companies on FDA submissions and management of clinical studies. Amy previously served as Vice President at Health Policy Associates Inc. and for the past two years has been an independent consultant. Amy received her JD from Tulane University in 1991 and her MPH (with concentrations in Health Law and Health Services) from Boston University in 1994.
Thomas Travison, PhD
Tom Travison is Associate Professor of Medicine at Harvard Medical School, and Senior Scientist at the Marcus Institute for Aging Research, Hebrew SeniorLife, where he directs the Biostatistics and Data Science center and is co-director of the center for Interventional Studies. His collaborative work is focused on multimodal interventions for the prevention and amelioration of syndromes of aging. His laboratory also focuses on the development and dissemination of software tools for reproducible biomedical research.
Victoria Lattanzi, MS
Victoria Lattanzi is a graduate of Brown University with a BS in Biology and Boston University School of Medicine with an MS in Clinical Investigation. Victoria started her research career as a bench scientist working in various academic laboratories throughout Boston, MA and developed extensive in vitro and in vivo pre-clinical technical skills. She is published in the fields of hematology/oncology, regenerative biology and biochemistry.
In 2010 she made the transition to clinical research and has gained extensive clinical trial experience in an academic setting. As a Clinical Research Associate within the Boston University Amyloidosis Center, Victoria was responsible for the management of the Center’s clinical trials. Her responsibilities included coordination of study start-up activities, regulatory submissions, subject recruitment, coordination of study visits and data collection. In 2016, she moved from site level clinical research to the industry side as she joined Halloran Consulting Group as a consultant within the biotechnology and pharmaceutical practice area. In this role, she worked as part of project teams to provide clinical operational support to clients in the life sciences industry. Currently, Victoria is working as a Clinical Trial Manager at BlueRock Therapeutics, an engineered cell therapy company headquartered in Cambridge, MA.
Marissa Volpe, MS
Marissa Volpe is a graduate of Framingham State University where she received her BS in Biology. Marissa started her career working as a Clinical Lab Technologist in an HLA lab in Boston (Center for Blood Research) where she was responsible for performing typing for HLA Class I and Class II antigens and alleles by using molecular DNA typing methods. In 1997, Marissa made the transition to drug development where she gained extensive experience working at a CRO (Contract Research Organization) and small/large Biopharmaceutical companies across Boston and in London.
Marissa’s first role in the industry was as a Clinical Data Manager where she was responsible for overseeing the collection of clinical trial data from multiple sources. Data is not only key to new drug submissions but also key in making decisions, whether easy or tough. Marissa’s goal was to ensure that any data her or the team provided was pristine and could stand up to any regulatory inspection. During her time as a Clinical Data Manager, she had the opportunity to work in the London Office for Biogen, where she built a small data management group who had responsibility for several projects.
After working in Data Management for 9 years, Marissa decided it was time for a change. In 2006, she moved from the data side of drug development to clinical operations where she started as a Clinical Trial Manager (CTM) responsible for running her own study. The Clinical Operations function of a company is key to the delivery of clinical trials which includes designing, planning and physically running Phase I – IV clinical trials. As a CTM, your role is to lead delivery of that clinical trial. Once Marissa got into the Clinical Operations group, she continued to develop and hold positions of increasing responsibility. Marissa had some great opportunities during her time at Biogen and then Genzyme where she sat in the bull-pen for an FDA Advisory Committee, its not common for Clinical Operations to be part of that process.
Marissa has worked in multiple therapeutic areas but her main therapeutic area of expertise was in Multiple Sclerosis. However, in Oct 2015, she moved to an Oncology company where she got the chance to work on multiple programs to treat certain cancers. Along with transitioning to Oncology, she also was the Head of Clinical Operations and built a high performing team to support the company’s objectives in delivering potentially life changing drugs to patients with cancer.
Marissa is very passionate about her job and feels that she plays a role in making a difference in patients lives. Her reason for getting up in the morning, even if she’s tired, is for the patient because they are waiting for the next treatment to either prolong or change their lives.